focus -WSS

focus

author：hotspot 2025-09-28 21:05:55 - browse：9

Geoff Martha, CEO of Medtronic Courtesy Medtronic

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area.

The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish. Medtronic has tried to become more streamlined in recent years — the company announced plans last year to spin off its patient monitoring and respiratory businesses, which Reuters recently reported, citing unnamed sources, may go to the Carlyle Group, a private equity firm.

Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean patch pump maker EOFlow, but EOFlow is enmeshed in a patent battle with Insulet. A federal judge blocked EOFlow from selling its wearable patch pumps earlier this month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： STAT letters to the editor on burnt

explore

hotspot

WSS

Wildfire smoke exposes gaps in outdoor worker protections

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Guidelines to prevent youth baseball injuries need more muscle

Walensky prepares to leave CDC — and Congress — behind

Roche to buy Carmot Therapeutics, developer of obesity drugs

New air purifier tech could be key to improving indoor air quality

hotspot

focus

knowledge

Apple is now the first public company to be valued at $3 trillion

Teach medical students about patients with intellectual disabilities

Trump demands the U.S. pay no more for drugs than other countries … again

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Supreme Court strikes down use of affirmative action

Guidelines to prevent youth baseball injuries need more muscle

Duchenne breakthrough therapy leaves behind pioneering families

Hollywood unions extend contract negotiations for actors

Medical leaders decry Supreme Court decision on affirmative action

Roche to buy Carmot Therapeutics, developer of obesity drugs

knowledge

Virginia high school admissions case could be legal follow

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What PEPFAR has meant on the ground in Ukraine

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Tori Bowie and the unacceptable rates of Black maternal death

Spinal cord stimulation reduces pain in amputees, study finds

focus

explore

hotspot

explore